NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $252,000 | -59.0% | 130,654 | +1.1% | 0.00% | – |
Q4 2021 | $614,000 | -46.8% | 129,175 | -7.8% | 0.00% | – |
Q3 2021 | $1,155,000 | -11.1% | 140,110 | -0.5% | 0.00% | – |
Q2 2021 | $1,299,000 | -25.6% | 140,760 | -0.8% | 0.00% | -100.0% |
Q1 2021 | $1,747,000 | -58.8% | 141,881 | -52.8% | 0.00% | 0.0% |
Q4 2020 | $4,242,000 | +15.4% | 300,846 | -1.8% | 0.00% | 0.0% |
Q3 2020 | $3,675,000 | +6.3% | 306,212 | +47.0% | 0.00% | 0.0% |
Q2 2020 | $3,458,000 | – | 208,295 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
XTX Topco Ltd | 10,018 | $48,000 | 0.03% |